Skip to main content
Clinical Trials/EUCTR2012-003544-68-IT
EUCTR2012-003544-68-IT
Active, not recruiting
Not Applicable

Randomized cross-over study of patient preference for oral or intravenous vinorelbine in the treatment of advanced NSCLC. A phase IV study. - VIVOS

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI
Status
Active, not recruiting
Last Updated
13 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 11, 2012
End Date
TBD
Last Updated
13 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients affected by stage IIIB or stage IV NSCLC candidates to receive a first line chemotherapy with vinorelbine due to age \= 70 and Eastern Cooperative Oncology Group (ECOG) Performance status \=2 or age \= 70 but ECOG PS \= 2
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 50
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 70

Exclusion Criteria

  • 1\. Patients who have had previous chemotherapy for lung cancer or radiotherapy on target lesions.
  • 2\. Participation in another clinical trial with any investigational agents within 30 days prior to study screening.
  • 3\. Presence of infection.
  • 4\. Preexisting clinically significant peripheral neuropathy.

Outcomes

Primary Outcomes

Not specified

Similar Trials